scholarly article | Q13442814 |
P50 | author | Ayalew Tefferi | Q66370740 |
P2093 | author name string | D Chen | |
A Pardanani | |||
C A Hanson | |||
C Finke | |||
C Brooks | |||
M M Patnaik | |||
K K Reichard | |||
E Rowinsky | |||
T K Kimlinger | |||
T Lasho | |||
D Zblewski | |||
P2860 | cites work | The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells | Q28140494 |
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients | Q33415505 | ||
SL-401 and SL-501, targeted therapeutics directed at the interleukin-3 receptor, inhibit the growth of leukaemic cells and stem cells in advanced phase chronic myeloid leukaemia | Q34098428 | ||
The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment | Q37151676 | ||
Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management | Q38110527 | ||
CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies | Q38186870 | ||
Failure to detect IL-3-binding sites on human mast cells | Q41714666 | ||
A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all thr | Q42639273 | ||
Severe acute interstitial lung disease after crizotinib therapy in a patient with EML4-ALK-positive non-small-cell lung cancer | Q44054776 | ||
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia. | Q51051082 | ||
Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies. | Q53646273 | ||
Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. | Q54447022 | ||
Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice | Q70292216 | ||
P433 | issue | 7 | |
P921 | main subject | mast cell | Q191989 |
interleukins | Q194908 | ||
P304 | page(s) | 1605-1608 | |
P577 | publication date | 2015-02-02 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells. | |
P478 | volume | 29 |